However, the correlation between the severity of the renal injury, as measured by serum creatinine, and glomerular Panx1 expression observed in the diabetic patient group suggests the prognostic value of glomerular Panx1 expression and the potential of pharmacological Panx1 modulation in the treatment of DM-induced CKD. This evidence concerns the gene PANX1 and chronic kidney disease.